
Profound Medical Inc. (NASDAQ:PROF) is a commercial‑stage medical technology company headquartered in Mississauga, Ontario, focused on advancing care for prostate cancer and benign prostatic hyperplasia (BPH). Its flagship product, the FDA‑cleared TULSA‑PRO® system, delivers AI‑powered, MRI‑guided, incision‑free robotic ablation of prostate tissue. The platform offers clinicians real‑time precision and customizable treatment plans that maintain patient quality of life while achieving high clinical efficacy. By combining cutting‑edge imaging, robotics, and AI, Profound Medical provides a unique, reimbursement‑aligned solution that sets a new standard in prostate therapy.
The Strategic Program Manager will support fully-cycle planning, execution, and optimization of TULSA-PRO programs across clinical and operational workflows, and will foster relationships with healthcare providers to deliver exceptional patient outcomes and drive business objectives.
Profound Medical Inc. (NASDAQ:PROF) is a commercial‑stage medical technology company headquartered in Mississauga, Ontario, focused on advancing care for prostate cancer and benign prostatic hyperplasia (BPH). Its flagship product, the FDA‑cleared TULSA‑PRO® system, delivers AI‑powered, MRI‑guided, incision‑free robotic ablation of prostate tissue. The platform offers clinicians real‑time precision and customizable treatment plans that maintain patient quality of life while achieving high clinical efficacy. By combining cutting‑edge imaging, robotics, and AI, Profound Medical provides a unique, reimbursement‑aligned solution that sets a new standard in prostate therapy.